Tron Logo
Trade on HitBTC
Like this video

Financial MediLiVes

Join The Innovative AI Based Telemedicine system

MediLiVes has brought an opportune moment for a major and much-needed disruption of the current healthcare system. With telemedicine infusion with technology, doctors and patients alike can manage care remotely, increasing efficiency and outcomes.

3.8
4 3 expert ratings
Benchy 3.5
KYC
Experts
4.7
4.0
3.4
Review: coming soon PRO
~$500,000
value of tokens sold in ICO
Ended
Token
MLIV
Type
IEO launchpad
Price in ICO
0.0080 USD
Country
UK
Whitelist/KYC
KYC
Restricted areas
Afghanistan, Bosnia & Herzegovina, Cayman Island, Democratic peoples Republic of korea (DPRK), Ethiopia, Iran, Iraq, Pakistan, Srilanka, Syria, Trinidad, and Tobago , Tunisia, Uganda, the United States and Yemen.
preICO start
15th Jul 2019
preICO end
15th Aug 2019
ICO start
1st Oct 2019
ICO end
30th Nov 2019
Visit ICO website
Report

Financial

Token info

Token
MLIV
Platform
Ethereum
Type
ERC20
Price in ICO
0.0080 USD

Bonus

Slab 1 - 1 to 10 ETH = 25% Bonus Slab 2 - 10 - 50 ETH = 50% Bonus Slab 3 50 ETH Above = 100 % Bonus

Tokens for sale
6,000,000,000

Investment info

Min. investment
0.1 ETH
Accepting
ETH
Distributed in ICO
50%
Soft cap
1,000,000 USD
Hard cap
8,000,000 USD
Raised
$500,000
Add to bookmarks
ICO KYC Report
2 members invited
Sunny Ahonsi
Passed
John McKay
Passed
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

Tycoon

Tycoon serves as a secured interface between professional traders and end users.

Ended
4.5

2GETHER

2gether is a next generation banking platform that works solely for the benefit of its ...

4.3

LOHN

Lohncontrol develops a business platform for processing economy based on an innovative ...

3.7

UCOIN

A new generation cryptocurrency, backed by an international financial ecosystem, design...

119 days 7 hours left

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it